Jo Mori

1.1k total citations
66 papers, 945 citations indexed

About

Jo Mori is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Jo Mori has authored 66 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 14 papers in Physiology. Recurrent topics in Jo Mori's work include Neuroscience and Neuropharmacology Research (13 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Pain Mechanisms and Treatments (7 papers). Jo Mori is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Pain Mechanisms and Treatments (7 papers). Jo Mori collaborates with scholars based in Japan, United States and United Kingdom. Jo Mori's co-authors include Kyoichi Shimomura, Toshitaka Manda, MASANOBU KOHSAKA, Hisashi Satoh, Sanae Matsumoto, Sueo Mukumoto, Katsumasa Kobayashi, Hiroyuki Kikuchi, Masaaki Tomoi and Shoji Shibata and has published in prestigious journals such as Stroke, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jo Mori

63 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Mori Japan 17 346 210 173 170 95 66 945
Bhalchandra V. Joshi United States 23 788 2.3× 261 1.2× 435 2.5× 189 1.1× 67 0.7× 46 2.0k
Yutaka Uehara Japan 19 361 1.0× 96 0.5× 75 0.4× 293 1.7× 45 0.5× 60 1.2k
Teruyoshi Inoue Japan 18 442 1.3× 231 1.1× 143 0.8× 191 1.1× 91 1.0× 40 1.0k
George Grayson United States 11 239 0.7× 231 1.1× 119 0.7× 93 0.5× 361 3.8× 12 793
G. Kurt Hogaboom United States 18 515 1.5× 244 1.2× 98 0.6× 434 2.6× 93 1.0× 29 1.1k
Edward Leung Italy 24 1.0k 3.0× 379 1.8× 364 2.1× 156 0.9× 225 2.4× 52 2.2k
Giuseppina Morini Italy 17 257 0.7× 143 0.7× 184 1.1× 181 1.1× 127 1.3× 74 799
Jerome H. Fleisch United States 18 448 1.3× 231 1.1× 89 0.5× 520 3.1× 141 1.5× 51 1.2k
Marco Criscuoli Italy 18 419 1.2× 371 1.8× 79 0.5× 216 1.3× 68 0.7× 76 1.0k
Jutta Hegler Germany 9 742 2.1× 211 1.0× 153 0.9× 111 0.7× 40 0.4× 10 1.1k

Countries citing papers authored by Jo Mori

Since Specialization
Citations

This map shows the geographic impact of Jo Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Mori more than expected).

Fields of papers citing papers by Jo Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Mori. The network helps show where Jo Mori may publish in the future.

Co-authorship network of co-authors of Jo Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Mori. A scholar is included among the top collaborators of Jo Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Mori. Jo Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kadowaki, Makoto, Yukinori Nagakura, Masaaki Tomoi, Jo Mori, & MASANOBU KOHSAKA. (1993). Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.. Journal of Pharmacology and Experimental Therapeutics. 266(1). 74–80. 58 indexed citations
3.
Matsuo, Masahiko, et al.. (1993). Multiple Mediators and Mechanisms Are Involved in the Adaptive Cytoprotection Provided by Certain Mild Irritants. The Japanese Journal of Pharmacology. 63(2). 251–256. 11 indexed citations
4.
Koibuchi, Yasushi, et al.. (1993). Vasorelaxant mechanism of the new vasodilator, FK409. European Journal of Pharmacology Molecular Pharmacology. 246(3). 205–212. 28 indexed citations
5.
Furuichi, Yasuhisa, Shoji Takakura, Hisashi Satoh, Jo Mori, & MASANOBU KOHSAKA. (1992). The Effect of Nilvadipine, a Dihydropyridine Type Calcium Channel Blocker, on Local Cerebral Blood Flow in Rats.. The Japanese Journal of Pharmacology. 58(4). 457–460. 12 indexed citations
6.
Takakura, Shoji, Yasuhisa Furuichi, Hisashi Satoh, Jo Mori, & MASANOBU KOHSAKA. (1992). Effects of nilvadipine on neuronal function in the ischemic cat brain. Surgical Neurology. 37(4). 255–260. 7 indexed citations
7.
Takakura, Shoji, Keizo Sogabe, Hisashi Satoh, et al.. (1992). Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride. Neuroscience Letters. 141(2). 199–202. 28 indexed citations
8.
Ohara, Kaname, et al.. (1989). Possible involvement of a tumor necrosis factor (TNF)-like mediator as an endogenous pyrogen in fever induction by Nocardia rubra cell wall skeleton (N-CWS).. Chemical and Pharmaceutical Bulletin. 37(10). 2795–2798. 1 indexed citations
9.
Nakamura, Takaaki, et al.. (1989). Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.. The Japanese Journal of Pharmacology. 49(3). 317–324. 26 indexed citations
10.
Shimomura, Kyoichi, et al.. (1988). Recombinant human tumor necrosis factor‐α: Thrombus formation is a cause of anti‐tumor activity. International Journal of Cancer. 41(2). 243–247. 98 indexed citations
11.
Hiroi, Jun, Kaname Ohara, Katsumasa Kobayashi, et al.. (1988). Effects of FR50948, a new orally active antiallergic agent, in experimental allergic models.. The Japanese Journal of Pharmacology. 46(4). 337–348. 2 indexed citations
12.
Hirai, Osamu, et al.. (1987). Antitumour Activity of Purified Arabinogalactan-peptidoglycan Complex of the Cell Wall Skeleton of Rhodococcus lentifragmentus. Microbiology. 133(2). 369–373. 7 indexed citations
13.
Shimomura, Kyoichi, et al.. (1987). A new antitumor antibiotic, FR-900482. III. Antitumor activity in transplantable experimental tumors.. The Journal of Antibiotics. 40(5). 600–606. 67 indexed citations
14.
Hiroi, Jun, Takashi Fujii, Takehiro Ochi, et al.. (1985). The antiinflammatory effect of budesonide.. Folia Pharmacologica Japonica. 86(3). 219–231. 1 indexed citations
15.
Hiroi, Jun, Kaname Ohara, T Fujitsu, et al.. (1985). The anti-inflammatory effect of auranofin.. Folia Pharmacologica Japonica. 86(6). 441–455. 2 indexed citations
16.
Hiroi, Jun, Jo Mori, Toshiyuki Takashima, & Hiroyuki Kikuchi. (1984). Anti-allergic and anti-inflammatory activity of tiaramide hydrochloride. Ensho. 4(4). 311–312. 1 indexed citations
17.
Satoh, Hisashi, Jo Mori, Kyoichi Shimomura, Takaharu Ono, & Hiroyuki Kikuchi. (1984). Effect of Zimeldine, a New Antidepressant, on the Forced Swimming Test in Rats. The Japanese Journal of Pharmacology. 35(4). 471–473. 18 indexed citations
18.
Satoh, Hisashi, Yoshihiko Satoh, & Jo Mori. (1983). Effect of zotepine and various drugs on apomorphine- and methamphetamine-induced rotational behaviour in rats with unilateral lesions of the substantia nigra.. The Japanese Journal of Pharmacology. 33(2). 363–372. 5 indexed citations
19.
Uchida, Shinya, et al.. (1979). Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(10). 1588–94. 26 indexed citations
20.
Hattori, Keisuke, et al.. (1972). The effect of cold storage on the adrenergic mechanisms of intestinal smooth muscle. British Journal of Pharmacology. 46(3). 423–437. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhalchandra V. Joshi Breakdown of academic impact, for papers by Yutaka Uehara Breakdown of academic impact, for papers by Teruyoshi Inoue Breakdown of academic impact, for papers by George Grayson Breakdown of academic impact, for papers by G. Kurt Hogaboom Breakdown of academic impact, for papers by Edward Leung Breakdown of academic impact, for papers by Giuseppina Morini Breakdown of academic impact, for papers by Jerome H. Fleisch Breakdown of academic impact, for papers by Marco Criscuoli Breakdown of academic impact, for papers by Jutta Hegler
Rankless by CCL
2026